Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Surgery or Radiotherapy of the Primary Tumor in T1-2 Head and Neck Squamous Cell Carcinoma with Resectable N3 Nodes: A Multicenter GETTEC Study.
Carsuzaa F, Thariat J, Gorphe P, Righini C, Cosmidis A, Thureau S, Roge M, De Mones E, Servagi-Vernat S, Tonnerre D, Morinière S, Dugas A, Malard O, Pasquier F, Vergez S, Salleron J, Dufour X. Carsuzaa F, et al. Among authors: thureau s. Ann Surg Oncol. 2019 Oct;26(11):3673-3680. doi: 10.1245/s10434-019-07589-0. Epub 2019 Jul 1. Ann Surg Oncol. 2019. PMID: 31264120
[Conformal radiotherapy for vertebral bone metastasis].
Faivre JC, Py JF, Vogin G, Martinage G, Salleron J, Royer P, Grandgirard N, Pasquier D, Thureau S. Faivre JC, et al. Among authors: thureau s. Cancer Radiother. 2016 Oct;20(6-7):493-9. doi: 10.1016/j.canrad.2016.07.081. Epub 2016 Sep 7. Cancer Radiother. 2016. PMID: 27614498 Review. French.
Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
Chaput A, Calais J, Robin P, Thureau S, Bourhis D, Modzelewski R, Schick U, Vera P, Salaün PY, Abgral R. Chaput A, et al. Among authors: thureau s. Head Neck. 2017 Jun;39(6):1155-1165. doi: 10.1002/hed.24738. Epub 2017 Mar 6. Head Neck. 2017. PMID: 28263422
Benefit of cetuximab addition to a platinum-fluorouracil-based chemotherapy according to KRAS-LCS6 variant in an unselected population of recurrent and/or metastatic head and neck cancers.
Bastit V, Bon-Mardion N, Picquenot JM, Rainville V, Moldovan C, François A, Loeb A, Thureau S, Manu D, Jardin F, Marie JP, Di Fiore F, Clatot F. Bastit V, et al. Among authors: thureau s. Eur Arch Otorhinolaryngol. 2019 Feb;276(2):541-550. doi: 10.1007/s00405-018-5235-6. Epub 2018 Dec 6. Eur Arch Otorhinolaryngol. 2019. PMID: 30523411
[Prophylactic nodal radiotherapy for breast cancer].
Rogé M, Thureau S, Dampierre J, Dubray B, Rivera S. Rogé M, et al. Among authors: thureau s. Cancer Radiother. 2019 Dec;23(8):904-912. doi: 10.1016/j.canrad.2019.08.006. Epub 2019 Oct 5. Cancer Radiother. 2019. PMID: 31594695 Review. French.
Hadrontherapy Interactions in Molecular and Cellular Biology.
Thariat J, Valable S, Laurent C, Haghdoost S, Pérès EA, Bernaudin M, Sichel F, Lesueur P, Césaire M, Petit E, Ferré AE, Saintigny Y, Skog S, Tudor M, Gérard M, Thureau S, Habrand JL, Balosso J, Chevalier F. Thariat J, et al. Among authors: thureau s. Int J Mol Sci. 2019 Dec 24;21(1):133. doi: 10.3390/ijms21010133. Int J Mol Sci. 2019. PMID: 31878191 Free PMC article. Review.
[Construction of radiobiological models as TCP (tumor control probability) and NTCP (normal tissue complication probability): from dose to clinical effects prediction].
Chaikh A, Thariat J, Thureau S, Tessonnier T, Kammerer E, Fontbonne C, Dubray B, Balosso J, Fontbonne JM. Chaikh A, et al. Among authors: thureau s. Cancer Radiother. 2020 Jun;24(3):247-257. doi: 10.1016/j.canrad.2019.12.004. Epub 2020 Mar 24. Cancer Radiother. 2020. PMID: 32220563 French.
120 results